Che H, Zhang X, Cao L, Huang W, Lu Q
Genes (Basel). 2024; 15(11).
PMID: 39596660
PMC: 11593781.
DOI: 10.3390/genes15111461.
Wang J, Gan L, Liu F, Yang Q, Deng Q, Jiang D
Int J Biol Sci. 2024; 20(13):5343-5362.
PMID: 39430239
PMC: 11488585.
DOI: 10.7150/ijbs.92278.
Ramachandran R, Ibragimova S, Woods L, AlHouqani T, Gomez R, Simeoni F
iScience. 2024; 27(8):110500.
PMID: 39171293
PMC: 11338131.
DOI: 10.1016/j.isci.2024.110500.
Weidle U, Birzele F
Cancer Genomics Proteomics. 2024; 21(3):213-237.
PMID: 38670587
PMC: 11059596.
DOI: 10.21873/cgp.20442.
Chen C, He Y, Ni Y, Tang Z, Zhang W
J Cell Mol Med. 2024; 28(6):e18156.
PMID: 38429902
PMC: 10907849.
DOI: 10.1111/jcmm.18156.
FoxC1 activates limbal epithelial stem cells following corneal epithelial debridement.
Yang W, Lee S, Lehmann O, Wu Z, Hiriyanna S, Swaroop A
Exp Eye Res. 2023; 234:109599.
PMID: 37488009
PMC: 10530263.
DOI: 10.1016/j.exer.2023.109599.
The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis.
Yoshimura T, Li C, Wang Y, Matsukawa A
Cell Mol Immunol. 2023; 20(7):714-738.
PMID: 37208442
PMC: 10310763.
DOI: 10.1038/s41423-023-01013-0.
MicroRNA in adenoid cystic carcinoma (Review).
Li Y, Gu F, He Y, Xiang J, Huang X, Wang Y
Int J Oncol. 2022; 62(1).
PMID: 36484384
PMC: 9747198.
DOI: 10.3892/ijo.2022.5465.
Homo and Heterotypic Cellular Cross-Talk in Epithelial Ovarian Cancer Impart Pro-Tumorigenic Properties through Differential Activation of the Notch3 Pathway.
Mukherjee S, Sakpal A, Mehrotra M, Phadte P, Rekhi B, Ray P
Cancers (Basel). 2022; 14(14).
PMID: 35884426
PMC: 9319742.
DOI: 10.3390/cancers14143365.
Axenfeld-Rieger syndrome: orthopedic and orthodontic management in a pediatric patient: a case report.
Cazzolla A, Testa N, Spirito F, Di Cosola M, Campobasso A, Crincoli V
Head Face Med. 2022; 18(1):25.
PMID: 35804381
PMC: 9264492.
DOI: 10.1186/s13005-022-00329-y.
Enhancer recruitment of a RUNX1, HDAC1 and TLE3 co-repressor complex by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.
Simeoni F, Somervaille T
Mol Cell Oncol. 2022; 8(6):2003161.
PMID: 35419467
PMC: 8997249.
DOI: 10.1080/23723556.2021.2003161.
FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer.
Lu Y, Xu T, Iqbal M, Hsieh T, Luo Z, Liang G
Cancers (Basel). 2022; 14(7).
PMID: 35406487
PMC: 8996937.
DOI: 10.3390/cancers14071717.
miR-149 Suppresses the Proliferation and Metastasis of Human Gastric Cancer Cells by Targeting FOXC1.
Li D, Zhang Y, Li Y, Wang X, Wang F, Du J
Biomed Res Int. 2021; 2021:1503403.
PMID: 34957298
PMC: 8709748.
DOI: 10.1155/2021/1503403.
TET3- and OGT-Dependent Expression of Genes Involved in Epithelial-Mesenchymal Transition in Endometrial Cancer.
Ciesielski P, Jozwiak P, Forma E, Krzeslak A
Int J Mol Sci. 2021; 22(24).
PMID: 34948036
PMC: 8708691.
DOI: 10.3390/ijms222413239.
Theoretical Analysis of S, M and N Structural Proteins by the Protein-RNA Recognition Code Leads to Genes/proteins that Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis.
Nahalka J
Front Genet. 2021; 12:763995.
PMID: 34659373
PMC: 8511677.
DOI: 10.3389/fgene.2021.763995.
Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.
Simeoni F, Romero-Camarero I, Camera F, Amaral F, Sinclair O, Papachristou E
Cell Rep. 2021; 36(12):109725.
PMID: 34551306
PMC: 8480281.
DOI: 10.1016/j.celrep.2021.109725.
Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis.
Ray T, Ryusaki T, Ray P
Front Oncol. 2021; 11:721959.
PMID: 34540690
PMC: 8446626.
DOI: 10.3389/fonc.2021.721959.
[FOXC1 Knockdown Reverses Gefitinib Resistance in Non-small Cell Lung Cancer].
Peng C, Li P, Yang M, Chen D, Huang Y
Zhongguo Fei Ai Za Zhi. 2021; 24(8):538-547.
PMID: 34334155
PMC: 8387653.
DOI: 10.3779/j.issn.1009-3419.2021.103.11.
MicroRNA miR-106a-5p targets forkhead box transcription factor FOXC1 to suppress the cell proliferation, migration, and invasion of ectopic endometrial stromal cells via the PI3K/Akt/mTOR signaling pathway.
Zhou X, Chen Z, Pei L, Sun J
Bioengineered. 2021; 12(1):2203-2213.
PMID: 34082653
PMC: 8806537.
DOI: 10.1080/21655979.2021.1933679.
FOXC1 Negatively Regulates DKK1 Expression to Promote Gastric Cancer Cell Proliferation Through Activation of Wnt Signaling Pathway.
Jiang J, Li J, Yao W, Wang W, Shi B, Yuan F
Front Cell Dev Biol. 2021; 9:662624.
PMID: 33987183
PMC: 8111291.
DOI: 10.3389/fcell.2021.662624.